Schrodinger Inc Ordinary Shares SDGR
News
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger Reports Second Quarter 2026 Financial Results
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
